EBS vs BIOA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 09, 2026

EBS

32.7
AI Score
VS
BIOA Wins

BIOA

48.4
AI Score

Investment Advisor Scores

EBS

33score
Recommendation
SELL

BIOA

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EBS BIOA Winner
Revenue 390.40M 5.22M EBS
Net Income -173.40M -48.35M BIOA
Net Margin -44.4% -925.7% EBS
Operating Income -114.60M -54.71M BIOA
ROE -50.8% -12.9% BIOA
ROA -15.5% -12.2% BIOA
Total Assets 1.12B 396.93M EBS
Cash 139.70M 73.96M EBS
Current Ratio 5.42 17.19 BIOA
Free Cash Flow 17.80M -43.66M EBS

Relative Price Performance (Last 90 Days)

EBS 1M: +19.9% · 3M: -15.4% BIOA 1M: -32.3% · 3M: -74.5%

Current Technical Phase

EBS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.9 · Price: $6.81

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -40.1%), weak momentum, RSI 22

RSI (14): 22.4 · Price: $6.21

Fundamentals Snapshot

Metric EBS BIOA
Market Cap — —
Forward P/E 6.5 -2.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.7% 0.0%
Gross Margin 0.5% -7.5%
Operating Margin 0.3% -12.0%
EPS -3.40 -2.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.